These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 21939723

  • 1. Mucosal antibodies induced by tandem repeat of 2F5 epitope block transcytosis of HIV-1.
    Wang J, Xu L, Tong P, Chen YH.
    Vaccine; 2011 Nov 03; 29(47):8542-8. PubMed ID: 21939723
    [Abstract] [Full Text] [Related]

  • 2. Multiple tandem copies of conserved gp41 epitopes incorporated in gag virus-like particles elicit systemic and mucosal antibodies in an optimized heterologous vector delivery regimen.
    Jain S, Patrick AJ, Rosenthal KL.
    Vaccine; 2010 Oct 08; 28(43):7070-80. PubMed ID: 20723627
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Induction of systemic and mucosal cross-clade neutralizing antibodies in BALB/c mice immunized with human immunodeficiency virus type 1 clade A virus-like particles administered by different routes of inoculation.
    Buonaguro L, Visciano ML, Tornesello ML, Tagliamonte M, Biryahwaho B, Buonaguro FM.
    J Virol; 2005 Jun 08; 79(11):7059-67. PubMed ID: 15890945
    [Abstract] [Full Text] [Related]

  • 5. Induction of mucosal and systemic neutralizing antibodies against human immunodeficiency virus type 1 (HIV-1) by oral immunization with bovine Papillomavirus-HIV-1 gp41 chimeric virus-like particles.
    Zhang H, Huang Y, Fayad R, Spear GT, Qiao L.
    J Virol; 2004 Aug 08; 78(15):8342-8. PubMed ID: 15254206
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mucosal immunity to HIV-1: systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A).
    Staats HF, Nichols WG, Palker TJ.
    J Immunol; 1996 Jul 01; 157(1):462-72. PubMed ID: 8683152
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Isotype modulates epitope specificity, affinity, and antiviral activities of anti-HIV-1 human broadly neutralizing 2F5 antibody.
    Tudor D, Yu H, Maupetit J, Drillet AS, Bouceba T, Schwartz-Cornil I, Lopalco L, Tuffery P, Bomsel M.
    Proc Natl Acad Sci U S A; 2012 Jul 31; 109(31):12680-5. PubMed ID: 22723360
    [Abstract] [Full Text] [Related]

  • 13. Immunogenicity of neutralizing epitopes on multiple-epitope vaccines against HIV-1.
    Lu Y, Xiao Y, Ding J, Dierich M, Chen YH.
    Int Arch Allergy Immunol; 2000 Jan 31; 121(1):80-4. PubMed ID: 10686512
    [Abstract] [Full Text] [Related]

  • 14. Variable epitope libraries: new vaccine immunogens capable of inducing broad human immunodeficiency virus type 1-neutralizing antibody response.
    Charles-Niño C, Pedroza-Roldan C, Viveros M, Gevorkian G, Manoutcharian K.
    Vaccine; 2011 Jul 18; 29(32):5313-21. PubMed ID: 21600948
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. HIV-1 neutralizing antibodies in the genital and respiratory tracts of mice intranasally immunized with oligomeric gp160.
    VanCott TC, Kaminski RW, Mascola JR, Kalyanaraman VS, Wassef NM, Alving CR, Ulrich JT, Lowell GH, Birx DL.
    J Immunol; 1998 Feb 15; 160(4):2000-12. PubMed ID: 9469464
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.